Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-12-22

Clinical Trial Update: Supplementation of Glutamine and Fish Oil Versus Placebo in Patients With Heart Failure [Phase 2, Phase 3]

View source ↗

Summary

A phase 2/3 clinical trial evaluated supplementation with glutamine and fish oil versus placebo in patients with heart failure; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fish oil
  • Glutamine (glutamine)

Snippet

Sponsor: Columbia University | Conditions: Heart Failure | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2020-12-22